Claritev Corporation/$CTEV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Claritev Corporation
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Ticker
$CTEV
Sector
Primary listing
NYSE
Employees
2,700
Headquarters
Website
CTEV Metrics
BasicAdvanced
$1.2B
-
-$40.80
0.50
-
Price and volume
Market cap
$1.2B
Beta
0.5
52-week high
$74.07
52-week low
$4.80
Average daily volume
131K
Financial strength
Current ratio
0.976
Quick ratio
0.786
Long term debt to equity
-11,608.873
Total debt to equity
-11,656.873
Interest coverage (TTM)
0.18%
Profitability
EBITDA (TTM)
501.944
Gross margin (TTM)
74.43%
Net profit margin (TTM)
-70.91%
Operating margin (TTM)
6.72%
Effective tax rate (TTM)
14.69%
Revenue per employee (TTM)
$350,000
Management effectiveness
Return on assets (TTM)
0.73%
Return on equity (TTM)
-235.47%
Valuation
Price to revenue (TTM)
1.24
Price to book
-29.45
Price to tangible book (TTM)
-0.26
Price to free cash flow (TTM)
-21.093
Free cash flow yield (TTM)
-4.74%
Free cash flow per share (TTM)
-3.383
Growth
Revenue change (TTM)
-2.03%
Earnings per share change (TTM)
-43.66%
3-year revenue growth (CAGR)
-7.31%
3-year earnings per share growth (CAGR)
59.80%
Bulls say / Bears say
Claritev returned to topline growth with Q2 2025 revenues rising 3.5% year-over-year to $241.6 million, beating analyst forecasts and marking its first sequential increase after previous declines. (Nasdaq)
Strong operating cash generation drove free cash flow to a positive $36.6 million in Q2 2025, a marked improvement from a $7 million outflow in the prior-year period. (Nasdaq)
Analysts maintain a consensus ‘Buy’ rating on CTEV with an average price target of $86, implying approximately 55% upside from current levels. (Stockanalysis)
A U.S. judge ruled that out-of-network providers can pursue price-fixing claims against Claritev and major insurers, exposing the company to substantial antitrust litigation risk. (Reuters)
The U.S. Justice Department has sided with medical providers in alleging that Claritev’s pricing algorithms may facilitate anticompetitive behavior, increasing the probability of regulatory action and damages. (Reuters)
Claritev’s largest business line, Analytics-Based services, saw a 1.8% year-over-year revenue decline in Q2 2025, highlighting potential growth headwinds in its core segment. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.
CTEV News
AllArticlesVideos
Claritev Invests in Klaim, Inc. to Accelerate Provider Payment Solutions Across the U.S. and MENA Region
Business Wire1 day ago
Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call
Business Wire2 weeks ago
Claritev and iO Health Forge Strategic Relationship to Bring AI-Powered Revenue Cycle Management Optimization to the MENA Region
Business Wire3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Claritev Corporation stock?
Claritev Corporation (CTEV) has a market cap of $1.2B as of October 29, 2025.
What is the P/E ratio for Claritev Corporation stock?
The price to earnings (P/E) ratio for Claritev Corporation (CTEV) stock is 0 as of October 29, 2025.
Does Claritev Corporation stock pay dividends?
No, Claritev Corporation (CTEV) stock does not pay dividends to its shareholders as of October 29, 2025.
When is the next Claritev Corporation dividend payment date?
Claritev Corporation (CTEV) stock does not pay dividends to its shareholders.
What is the beta indicator for Claritev Corporation?
Claritev Corporation (CTEV) has a beta rating of 0.5. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.